A Dose of Economics

Office of Health Economics

Health economics. The people doing the work. The questions that matter. Despite 15+ years in health economics, Grace Hampson still has questions, and this podcast is her way of working through them out loud. Grace, a Director at the Office of Health Economics (OHE) hosts conversation with the world’s leading health economists, researchers and policy experts. Topics including HTA, NICE thresholds and cost-effectiveness, AMR, AI in health, drug shortages and the future of healthcare decision making. New episodes every Tuesday.

Episodes

  1. 6d ago

    AI and the future of health economics

    AI is already reshaping how healthcare policy works. The question is not whether AI will also transform health economics – but how quickly, and whether we are ready for the opportunities and challenges it could bring. There is incredible potential here, but also real questions about rigour, accountability, and what AI means for people working in this space.    Grace Hampson is joined by Tim Reason, co-founder and managing director of Estima Scientific, and Dalia Dawoud, Research Principal in HTA Policy and Strategy at Cytel to dive into all things AI and health economics.    A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud — debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. New episodes drop every Tuesday.  If there’s a topic you’d like us to cover, feel free to ⁠⁠share your ideas⁠⁠.

    35 min

  2. May 26

    Should HTA look beyond the healthcare system?

    When healthcare systems assess the value of a new medicine, should they only count the impact on the patient's health and the healthcare budget?     The case for a broader, societal perspective in health technology assessment has been building for years, but so have the arguments against it.     Grace Hampson is joined by Chris Skedgel, a Director at OHE, to dig into one of health economics' most contested methodological debates: what are health systems trying to achieve through health technology assessments (HTA)? And whose perspective should they adopt in doing so?    A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud — debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. New episodes drop every Tuesday.  For more on this topic, read OHE’s insight Valuing patient and carer time in HTA: equity and opportunity cost If there’s a topic you’d like us to cover, feel free to ⁠share your ideas⁠.

    37 min

  3. May 19

    Can joint clinical assessment speed up access to medicines?

    The Joint Clinical Assessment (JCA) is a milestone in European health policy, promising a single shared evaluation of the efficacy and safety of new medicines across EU member states. Theoretically, this should mean consistency for innovators and faster access to medicines for patients. But one year on, how is JCA working in practice, and what needs to happen next?     Grace Hampson is joined by Patrick Hopkinson, founder of PHTA Consulting and global market access expert, and Matthias Hofer, Senior Principal Economist at OHE, to take stock of the lessons learned from the first year of JCA, and discuss what’s yet to come.       A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud — debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. New episodes drop every Tuesday.     If there’s a topic you’d like us to cover, feel free to share your ideas.

    47 min

  4. May 12

    When antibiotics stop working: the hidden crisis in plain sight

    Around 5 million deaths per year are linked to antimicrobial resistance (AMR) and this number is growing, with AMR-related deaths predicted to surpass deaths from cancer by 2050. And yet, the global pipeline of new antibiotics is critically underdeveloped. So how do we address the problem?  Grace Hampson is joined by Lotte Steuten, Deputy Chief Executive of the Office of Health Economics and David McKinney, Co-founder of ARMoR, to dig into the market failures surrounding the AMR crisis and debate what it would take to turn the tide.  A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud — debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. New episodes drop every Tuesday.   If there’s a topic you’d like us to cover, feel free to share your ideas. Find the Lifeline album on Spotify

    40 min

  5. May 5

    Most Favored Nation pricing: what it means for policy, patients and pharma

    US pharmaceutical prices are the highest in the world -- President Trump's Most Favoured Nation (MFN) policy is trying to change that. But what does MFN pricing mean in practice? And what are the global ripple effects on drug innovation and R&D?   Grace Hampson is joined by Neil Grubert and Amanda Cole to talk about the biggest developments in U.S drug pricing policy – and what it means for the rest of the world.     A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud — debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. New episodes drop every Tuesday.   If there’s a topic you’d like us to cover, feel free to share your ideas.

    30 min

  6. Trailer

    Welcome to A Dose of Economics

    When demand for healthcare is growing but budgets are finite, the "how" and "why" of decision-making matters.  In this first episode, host Grace Hampson, a Director at the Office of Health Economics (OHE), introduces the podcast, and sets out what you can expect this season.  One question will run through every conversation: what can health economics bring to the most pressing problems in healthcare today?  From cost-effectiveness thresholds and health technology assessment (HTA), to AI in health economics, rare diseases, drug pricing policy, antibiotics, and prevention, A Dose of Economics gets to the heart of the matter with expert guests closest to the work.

    1 min

Trailer

About

Health economics. The people doing the work. The questions that matter. Despite 15+ years in health economics, Grace Hampson still has questions, and this podcast is her way of working through them out loud. Grace, a Director at the Office of Health Economics (OHE) hosts conversation with the world’s leading health economists, researchers and policy experts. Topics including HTA, NICE thresholds and cost-effectiveness, AMR, AI in health, drug shortages and the future of healthcare decision making. New episodes every Tuesday.

Information

  • Creator
    Office of Health Economics
  • Years Active
    2K
  • Episodes
    6
  • Rating
    Clean
  • Copyright
    © Office of Health Economics
  • Show Website
    A Dose of Economics